Identifying the drivers of patients’ reliance on short-acting β2-agonists in asthma
Journal of Asthma, DOI: 10.1080/02770903.2020.1761382 Sarah Blakeston , MA,Gavin Harper , BA &Julen Zabala Mancebo , BEng, MSc, PhD Abstract Background: One of the most commonly observed asthma treatment patterns is the underuse of inhaled corticosteroid (ICS)…